AIM/AGY (AIM/AGY)

London Stock Exchange AIM: AIM/AGY · GBX

GBX 4.20

-0.05 (-1.2%)· Recorded snapshot

Market cap	266M
Revenue (ttm)	57.3M
Net income (ttm)	-48.2M
EPS (ttm)	-GBX 0.01
Shares out	6.3B
Volume	526,079
Beta	0.92

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 57.3M
Net income (ttm): -48.2M
EPS (ttm): -GBX 0.01
Market cap: 266M

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROEn/a

P25 n/aP50 n/aP75 n/a

ROIC-163.2

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All AIM/AGY indicators

Market & fundamental data

Available fields

198

Groups with data

Currency

GBP

Showing 198 of 198 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	GBP
Country	United Kingdom
Country code	UK
Earnings date	2026-12-11
Employees	584
Employees change	-18
Employees growth	-2.99%
Enterprise value	GBX 282.6M
Exchange	London Stock Exchange AIM
Financial currency	GBP
Financial report date	2025-12-31
First seen	2026-05-10
Fiscal year end	June
Founded	1998
Industry	Drug Manufacturers - Specialty & Generic
Is primary listing	Yes
ISIN number	GB00B02LCQ05
Last earnings date	2025-12-29
Last refreshed	2026-10-28
Market cap	GBX 266M
Next earnings date	2026-12-11
Price	GBX 4.20
Price currency	GBX
Sector	Healthcare
SIC code	2836
Stock price date	2026-10-28
Symbol	aim/AGY
Website	https://www.allergytherapeutics.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings yield	-22.96%
EV/Sales	4.99x
FCF / EV yield	-13%
FCF yield	-13.81%
Industry forward P/E	16.83x
Industry P/E	20.85x
P/B ratio	63.34x
P/S ratio	4.7x
Price / tangible book value	5,492.5x
Sector forward P/E	14.49x
Sector P/E	22.58x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	-59.58%
EBITDA margin	-55.16%
Gross margin	52.22%
Operating margin	-59.58%
Pretax margin	-82.33%
Profit margin	-84.08%
Profit per employee	GBX -82,491
Revenue per employee	GBX 98,106
ROA	-29.64%
ROA (5Y)	-19.42%
ROCE	-87.58%
ROIC	-163.21%
ROIC (5Y)	-80.42%
SBC / revenue	3.42%
Tax / revenue	1.76%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth years	2
Gross profit growth	-0.53%
Gross profit growth (Q)	2.96%
Gross profit growth 3Y	-8.75%
Gross profit growth 5Y	-13.33%
Net income growth years	2
Revenue growth	2.94%
Revenue growth (Q)	6.61%
Revenue growth (QoQ)	72.65%
Revenue growth 10Y	2.67%
Revenue growth 3Y	-3.61%
Revenue growth 5Y	-6.87%
Revenue growth quarters	1
Revenue growth years	0

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	GBX -4.6M
Depreciation and amortization	GBX 2.5M
EBIT	GBX -34.1M
EBITDA	GBX -31.6M
EPS	GBX -0.01
FCF per share	GBX -0.01
Financing cash flow	GBX 25.5M
Free cash flow	GBX -37.2M
Free cash flow minus SBC	GBX -39.1M
Gross profit	GBX 29.9M
Income taxes	GBX 1M
Investing cash flow	GBX -4.2M
Net borrowing	GBX 26.7M
Net cash flow	GBX -11.6M
Net income	GBX -48.2M
Operating cash flow minus SBC	GBX -34.5M
Operating income	GBX -34.1M
Revenue	GBX 57.3M
Stock-based compensation	GBX 2M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	-2.17
Book value per share	GBX 0.00
Debt / equity	6.3
Goodwill	GBX 3.3M
Interest coverage	-4.88
Long-term assets	GBX 34.8M
Long-term liabilities	GBX 34.7M
Net cash (debt)	GBX -16.7M
Net cash / market cap	-6.19%
Net debt / equity	3.92
Piotroski F-Score	3
Property, plant and equipment	GBX 26.4M
Shareholders' equity	GBX 4.2M
Tangible book value	GBX 49,000
Tangible book value per share	GBX 0.00
Total assets	GBX 71M
Total cash	GBX 10.1M
Total debt	GBX 26.8M
Total liabilities	GBX 66.8M
WACC	10.36%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.8
Current assets	GBX 36.3M
Current liabilities	GBX 32M
Current ratio	1.13
Inventory turnover	2.13
Net working capital	GBX -3.9M
Quick ratio	0.7
Working capital	GBX 4.2M
Working capital turnover	5.74

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-4.81%
Shareholder yield	-4.81%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y price change	-81.94%
10Y return CAGR	-8.93%
10Y total return	-60.76%
150-day SMA	GBX 7.11
15Y price change	-62.26%
15Y return CAGR	-1.31%
15Y total return	-17.98%
1D price change	-1.18%
1M price change	-11.58%
1M total return	-11.58%
1W price change	-6.67%
1W total return	-6.67%
1Y price change	-48.78%
1Y return CAGR	-48.8%
1Y total return	-48.78%
20-day SMA	GBX 4.59
200-day SMA	GBX 8.14
20Y price change	-96%
20Y return CAGR	-11.5%
20Y total return	-91.31%
3M price change	-22.22%
3M total return	-22.22%
3Y price change	189.66%
3Y return CAGR	42.54%
3Y total return	189.66%
50-day SMA	GBX 4.89
50-day SMA vs 200-day SMA	50under200
52-week high	GBX 12.10
52-week high date	2026-02-26
52-week low	GBX 3.97
52-week low date	2026-10-28
5Y price change	-87.74%
5Y return CAGR	-23.25%
5Y total return	-73.36%
6M price change	-61.47%
6M total return	-61.47%
All-time high	GBX 146.00
All-time high date	2007-02-05
All-time low	GBX 0.80
All-time low date	2023-06-22
Average true range (ATR)	GBX 0.40
Average volume	122.4K
Beta (1Y)	0.07
Beta (2Y)	0.38
Beta (5Y)	0.92
Change from 52-week high	-65.29%
Change from 52-week low	5.79%
Change from all-time high	-97.12%
Change from all-time low	425%
Change from open	-0.78%
Day's gap	-0.4%
Dollar volume	GBX 2.2M
High price	GBX 4.50
Low price	GBX 3.97
Monthly RSI	34.2
Open price	GBX 4.23
Position in 52-week range	43.4%
Previous close	GBX 4.25
Price vs 150-day SMA	-40.91%
Price vs 20-day SMA	-8.52%
Price vs 200-day SMA	-48.42%
Price vs 50-day SMA	-14.11%
Relative volume	4.3
RSI	14.2
Sharpe ratio	-0.92
Sharpe ratio (3Y)	0.76
Sharpe ratio (5Y)	0.25
Sortino ratio	-1.15
Sortino ratio (3Y)	1.23
Sortino ratio (5Y)	0.39
Volume	526.1K
Weekly RSI	24.37
YTD price change	-61.82%
YTD total return	-61.82%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	723.8M
Shares change (QoQ)	9.62%
Shares change (YoY)	4.81%
Shares held by insiders	0.14%
Shares held by institutions	6.82%
Shares outstanding	6.3B

Deeper analysis on AIM/AGY

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this AIM/AGY report

Is a complete AIM/AGY research report available?

No complete published report is available for aim/AGY (AIM/AGY) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

AIM/AGY (AIM/AGY)

Price

Financial snapshot

Fair-value bridge

Latest news · AIM/AGY

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All AIM/AGY indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on AIM/AGY

Frequently asked questions